HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olaf Ortmann Selected Research

N- (2- diethylaminoethyl)- N- (2- hydroxy- 2- phenylethyl)- 2,5- dichloroaniline

2/2013Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olaf Ortmann Research Topics

Disease

70Breast Neoplasms (Breast Cancer)
10/2022 - 07/2003
61Neoplasms (Cancer)
10/2022 - 01/2004
19Endometrial Neoplasms (Endometrial Cancer)
07/2021 - 08/2006
18Ovarian Neoplasms (Ovarian Cancer)
09/2021 - 05/2002
8Neoplasm Metastasis (Metastasis)
02/2022 - 06/2012
8Triple Negative Breast Neoplasms
10/2020 - 07/2009
7Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2022 - 05/2019
6Adenocarcinoma
01/2020 - 11/2005
3Infertility (Sterility)
07/2020 - 01/2003
3Carcinogenesis
05/2017 - 04/2008
3Atrophy
06/2014 - 05/2012
3Endometriosis
10/2011 - 04/2010
2Neoplasm Micrometastasis
06/2021 - 01/2019
2Primary Ovarian Insufficiency
06/2021 - 06/2011
2Lymphatic Metastasis
10/2020 - 01/2020
2Inflammation (Inflammations)
07/2019 - 01/2017
2Diabetes Mellitus
01/2004 - 12/2003
1Cardiovascular Diseases (Cardiovascular Disease)
06/2021
1Osteoporosis
06/2021
1Dementia (Dementias)
06/2021
1Mesothelioma
01/2021

Drug/Important Bio-Agent (IBA)

32Estrogen ReceptorsIBA
10/2022 - 03/2004
30Estrogens (Estrogen)FDA Link
10/2022 - 07/2003
23Hormones (Hormone)IBA
09/2021 - 01/2004
18TamoxifenFDA LinkGeneric
07/2020 - 03/2004
13Messenger RNA (mRNA)IBA
01/2021 - 11/2005
11Estrogen Receptor alphaIBA
12/2020 - 07/2003
10Trastuzumab (Herceptin)FDA Link
03/2022 - 11/2007
9Protein Isoforms (Isoforms)IBA
10/2022 - 11/2005
8Aromatase InhibitorsIBA
01/2020 - 01/2004
7Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2014 - 01/2003
7Estradiol (Delestrogen)FDA LinkGeneric
04/2014 - 07/2003
7Estrogen Receptor betaIBA
10/2011 - 01/2007
6SteroidsIBA
09/2021 - 09/2012
6Small Interfering RNA (siRNA)IBA
01/2020 - 03/2010
5Proteins (Proteins, Gene)FDA Link
09/2021 - 03/2008
5GTP-Binding Proteins (G-Protein)IBA
12/2020 - 11/2013
4Complement System Proteins (Complement)IBA
10/2022 - 04/2010
4G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
07/2019 - 01/2006
3Pharmaceutical PreparationsIBA
05/2022 - 03/2005
3Fulvestrant (Faslodex)FDA Link
01/2021 - 01/2006
3Estrogen Receptor Modulators (Antiestrogen)IBA
01/2021 - 01/2006
3Glucose (Dextrose)FDA LinkGeneric
07/2019 - 12/2003
3Paclitaxel (Taxol)FDA LinkGeneric
02/2018 - 05/2002
3exemestane (Aromasin)FDA Link
08/2017 - 01/2004
3ERB 041IBA
05/2017 - 01/2014
3liquiritigeninIBA
05/2017 - 02/2013
3WAY 200070IBA
05/2017 - 01/2014
3Cholecalciferol (Vitamin D3)FDA Link
12/2016 - 08/2002
3Progesterone Receptors (Progesterone Receptor)IBA
12/2015 - 01/2010
3Cyclin A2IBA
06/2012 - 06/2007
3Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
04/2012 - 11/2008
2Phenobarbital (Luminal)FDA Link
10/2022 - 01/2022
2Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2013
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
06/2021 - 01/2020
2pertuzumabIBA
01/2020 - 09/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 07/2019
2Biological ProductsIBA
10/2018 - 06/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2014 - 08/2009
2Immunoglobulins (Immunoglobulin)IBA
07/2014 - 09/2012
2AntibodiesIBA
07/2014 - 09/2012
2Estriol (Epiestriol)IBA
06/2014 - 04/2014
2Selective Estrogen Receptor Modulators (SERM)IBA
01/2014 - 01/2006
2Somatostatin Receptors (Somatostatin Receptor)IBA
02/2013 - 08/2009
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2013 - 08/2009
2LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
09/2012 - 04/2012
2ErbB Receptors (EGF Receptor)IBA
09/2012 - 09/2011
2Indicators and Reagents (Reagents)IBA
09/2012 - 12/2010
2Matrix Metalloproteinases (MMPs)IBA
06/2012 - 06/2010
2Epidermal Growth Factor (EGF)IBA
04/2012 - 07/2003
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2011 - 07/2003
2Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2011 - 08/2002
2CytokinesIBA
01/2011 - 11/2005
2Carboplatin (JM8)FDA LinkGeneric
09/2009 - 05/2002
1Protein Kinase CIBA
10/2022
1sotrastaurinIBA
10/2022
1Colloids (Colloid)IBA
06/2021
1apratastatIBA
05/2021
13- (formylhydroxyamino)- 2- (3- phenyl- 1- propyl)butanoic acid (2,2- dimethyl- 1- methylcarbamoyl- 1- propyl)amideIBA
05/2021
1ChemokinesIBA
05/2021
1CrizotinibIBA
01/2021

Therapy/Procedure

43Therapeutics
05/2022 - 03/2004
10Drug Therapy (Chemotherapy)
02/2022 - 05/2002
6Aftercare (After-Treatment)
01/2021 - 11/2005
5Lymph Node Excision (Lymph Node Dissection)
10/2020 - 01/2019
4Adjuvant Chemotherapy
03/2022 - 02/2009
4Radiotherapy
02/2022 - 11/2018
3Palliative Care (Palliative Therapy)
02/2022 - 11/2018
3Hysterectomy
01/2022 - 05/2019
3Hormone Replacement Therapy (Therapy, Hormone Replacement)
07/2020 - 04/2008
3Neoadjuvant Therapy
06/2019 - 09/2009
3Adjuvant Radiotherapy
01/2019 - 10/2018
3Transplantation
01/2017 - 11/2011
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2022 - 02/2022
2Brachytherapy
02/2022 - 02/2022
2Immunotherapy
01/2018 - 01/2017
2Curettage
12/2015 - 06/2010
1Heterologous Transplantation (Xenotransplantation)
01/2022
1Ambulatory Care (Outpatient Care)
12/2021
1Adjuvant Chemoradiotherapy
01/2021